300347-基本财务实时评分详情
泰格医药300347基本财务实时评分详情
更新时间:2020-11-24 00:00:01
股票代码
300347
当期评分
股票名称
泰格医药
报告日期2017-12-312018-12-312019-12-312020-03-312020-06-302020-06-30
每股经营现金流(¥)0.62971.04410.70380.11860.2931
销售净利润率(%)19.689822.028334.791839.890971.3451
销售毛利率(%)42.661142.703446.084845.895448.0797
净资产收益率(%)12.0217.6919.925.6419.26
营业增长率(%)43.633836.373121.84816.76918.577
净利润增长率(%)111.871252.570292.448370.9034173.9126
每股收益(%)0.60180.9441.130.34021.3444
现金流量比率(%)44.021743.20929.46114.621610.1118
三项费用比重(%)20.008416.345115.705516.283215.8516
每股净资产(¥)5.00535.33535.63766.03066.9193
流动比率(%)1.88071.32651.88191.81951.7605
速动比率(%)1.88061.32611.88131.81821.7599
现金比率(%)75.018658.2875114.0512107.1841107.1841
总资产利润率(%)11.125312.890816.51353.287912.3324
主营利润比重%166.8888162.1029118.6142104.595961.9815
应收账款(万元)63,168.6878,093.87107,472.2237,600.4141,277.85
应收票据(万元)--73.42567.02496.73372.76
预付款项(万元)3,139.674,715.772,607.963,767.963,511.40
存货(万元)1.4051.89120.56241.25129.64
在建工程(万元)----2,230.912,454.931,326.47
应付款项(万元)2,395.634,402.757,519.156,298.586,038.85
长期借款(万元)1,742.46343.173,650.0013,610.0013,610.00
未分配利润(万元)66,897.35101,070.23179,596.43205,093.37255,499.53
商誉(万元)104,902.68103,292.69115,783.09136,312.36135,468.11
流动资产(万元)223,757.75267,654.08416,269.14474,156.69544,281.50
流动负债(万元)71,549.07120,864.22179,069.23192,394.12217,250.13
泰格医药300347评分结果
87.88分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006